5002
Abdominal wall ulceration and mucinosis secondary to recombinant human interferon - beta-1b .
 adverse effect: Abdominal wall ulceration, recombinant human interferon - beta-1b; adverse effect: mucinosis, recombinant human interferon - beta-1b
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  Abdominal wall ulceration, recombinant human interferon - beta-1b; mucinosis, recombinant human interferon - beta-1b 
Answer:
 adverse effect: Abdominal wall ulceration, recombinant human interferon - beta-1b; adverse effect: mucinosis, recombinant human interferon - beta-1b